Maija Suvanto1, Timo Jahnukainen2, Marjo Kestilä3, Hannu Jalanko2. 1. Children's Hospital, University of Helsinki and Helsinki University Central Hospital, Tukholmankatu 8, 00290, Helsinki, Finland. maija.suvanto@helsinki.fi. 2. Children's Hospital, University of Helsinki and Helsinki University Central Hospital, Tukholmankatu 8, 00290, Helsinki, Finland. 3. Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland.
Abstract
BACKGROUND: Podocyte foot process effacement is a uniform finding in kidneys with heavy proteinuria. Its molecular mechanisms, however, are unsolved. We analyzed the expression of podocyte proteins in two kidney disorders: Congenital nephrotic syndrome of the Finnish type (CNF) and minimal change nephrotic syndrome (MCNS). METHODS: Immunoperoxidase and immunofluorescence stainings were used to semiquantitatively analyze the expression of 13 and 4 podocyte proteins from different cellular compartments in CNF and MCNS, respectively. RESULTS: The expression of a major slit diaphragm (SD) protein, Neph 1, showed a 46-fold decrease (p < 0.0001) in CNF kidneys as compared to controls. The three cytosolic adaptor proteins, podocin, NCK1/2, CD2AP, connecting SD proteins to the actin cytoskeleton were slightly upregulated (1.1-fold, 1.4-fold, and 3.3-fold, respectively). Also, the staining of the two actin-regulator proteins, ACTN4 and INF2, was modestly increased (2.2-fold and 1.7-fold, respectively, p < 0.0001). Staining for α3-integrin showed 1.9-fold increase (p < 0.0001) indicating that the major podocyte anchoring complex, α3β1, was well preserved in CNF glomeruli. In contrast to CNF kidneys, Neph1 FAT1, ACTN4, and CD2AP were quite normally expressed in proteinuric and non-proteinuric MCNS kidneys. CONCLUSION: CNF kidneys lacking nephrin show decreased expression of other SD proteins but not cytosolic podocyte proteins involved in the foot process architecture or function. In MCNS kidneys, these changes in expression were not observed.
BACKGROUND: Podocyte foot process effacement is a uniform finding in kidneys with heavy proteinuria. Its molecular mechanisms, however, are unsolved. We analyzed the expression of podocyte proteins in two kidney disorders: Congenital nephrotic syndrome of the Finnish type (CNF) and minimal change nephrotic syndrome (MCNS). METHODS: Immunoperoxidase and immunofluorescence stainings were used to semiquantitatively analyze the expression of 13 and 4 podocyte proteins from different cellular compartments in CNF and MCNS, respectively. RESULTS: The expression of a major slit diaphragm (SD) protein, Neph 1, showed a 46-fold decrease (p < 0.0001) in CNF kidneys as compared to controls. The three cytosolic adaptor proteins, podocin, NCK1/2, CD2AP, connecting SD proteins to the actin cytoskeleton were slightly upregulated (1.1-fold, 1.4-fold, and 3.3-fold, respectively). Also, the staining of the two actin-regulator proteins, ACTN4 and INF2, was modestly increased (2.2-fold and 1.7-fold, respectively, p < 0.0001). Staining for α3-integrin showed 1.9-fold increase (p < 0.0001) indicating that the major podocyte anchoring complex, α3β1, was well preserved in CNF glomeruli. In contrast to CNF kidneys, Neph1FAT1, ACTN4, and CD2AP were quite normally expressed in proteinuric and non-proteinuric MCNS kidneys. CONCLUSION:CNF kidneys lacking nephrin show decreased expression of other SD proteins but not cytosolic podocyte proteins involved in the foot process architecture or function. In MCNS kidneys, these changes in expression were not observed.
Authors: Jaakko Patrakka; Vesa Ruotsalainen; Ilkka Ketola; Christer Holmberg; Markku Heikinheimo; Karl Tryggvason; Hannu Jalanko Journal: J Am Soc Nephrol Date: 2001-02 Impact factor: 10.121
Authors: T Inoue; E Yaoita; H Kurihara; F Shimizu; T Sakai; T Kobayashi; K Ohshiro; H Kawachi; H Okada; H Suzuki; I Kihara; T Yamamoto Journal: Kidney Int Date: 2001-03 Impact factor: 10.612
Authors: D B Donoviel; D D Freed; H Vogel; D G Potter; E Hawkins; J P Barrish; B N Mathur; C A Turner; R Geske; C A Montgomery; M Starbuck; M Brandt; A Gupta; R Ramirez-Solis; B P Zambrowicz; D R Powell Journal: Mol Cell Biol Date: 2001-07 Impact factor: 4.272
Authors: K Schwarz; M Simons; J Reiser; M A Saleem; C Faul; W Kriz; A S Shaw; L B Holzman; P Mundel Journal: J Clin Invest Date: 2001-12 Impact factor: 14.808
Authors: Eva M Kovacs; Suzie Verma; Radiya G Ali; Aparna Ratheesh; Nicholas A Hamilton; Anna Akhmanova; Alpha S Yap Journal: Nat Cell Biol Date: 2011-07-24 Impact factor: 28.824
Authors: Anne-Tiina Lahdenkari; Kari Lounatmaa; Jaakko Patrakka; Christer Holmberg; Jorma Wartiovaara; Marjo Kestilä; Olli Koskimies; Hannu Jalanko Journal: J Am Soc Nephrol Date: 2004-10 Impact factor: 10.121
Authors: M Kestilä; U Lenkkeri; M Männikkö; J Lamerdin; P McCready; H Putaala; V Ruotsalainen; T Morita; M Nissinen; R Herva; C E Kashtan; L Peltonen; C Holmberg; A Olsen; K Tryggvason Journal: Mol Cell Date: 1998-03 Impact factor: 17.970
Authors: Lívia Helena de Morais Pereira; Crislaine Aparecida da Silva; Maria Luíza Gonçalves Dos Reis Monteiro; Liliane Silvano Araújo; Laura Penna Rocha; Marcelo Bernardes da Rocha Reis; Fernando Silva Ramalho; Rosana Rosa Miranda Corrêa; Marcos Vinicius Silva; Marlene Antonia Reis; Juliana Reis Machado Journal: PLoS One Date: 2019-06-12 Impact factor: 3.240